36C24221Q0158.docx

DOCX document 23 KB Posted

Attached to
6505--RADIOPHARMACY DELIVERIES - SYRACUSE NUCLEAR MEDICINE
Solicitation number
36C24221Q0158
Issued by

View the file

Other files

File Type Posted
SOW FINAL 10-25-2020.docx DOCX document

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Contract Opportunity Combined Synopsis/Solicitation Notice

PRODUCT SERVICE CODE

SUBJECT

CONTRACTING OFFICE'S

ZIP-CODE

SOLICITATION NUMBER

RESPONSE DATE/TIME/ZONE

ARCHIVE

DAYS AFTER THE RESPONSE DATE

RECOVERY ACT FUNDS

SET-ASIDE

NAICS CODE

CONTRACTING OFFICE

ADDRESS

POINT OF CONTACT

(POC Information Automatically Filled from User Profile Unless Entered)

DESCRIPTION

See Attachment

AGENCY'S URL

URL DESCRIPTION

AGENCY CONTACT'S EMAIL

ADDRESS

EMAIL DESCRIPTION

ADDRESS

POSTAL CODE

COUNTRY

ADDITIONAL INFORMATION

GENERAL INFORMATION

PLACE OF PERFORMANCE

* = Required Field Contract Opportunity Combined Synopsis/Solicitation Notice

RADIOPHARMACY DELIVERIES - SYRACUSE NUCLEAR MEDICINE

13210 36C24221Q0158 11-12-2020 16:00

EASTERN TIME, NEW YORK, USA

N 325412 Department of Veterans Affairs

NC 02

1304 Buckley Rd - Suite 104 Albany NY 12208-3410 Contracting Officer Denise Edmonds Denise.Edmonds@va.gov 315-4254696 Syracuse VA Medical Center 800 Irving Avenue Syracuse

NY

13210

USA

https://www.syracuse.com/ Syracuse VA Denise.Edmonds@va.gov Contract Officer See attached document: SOW FINAL 10-25-2020.

The Department of Veterans Affairs Central New York Healthcare System at Syracuse, located at 800 Irving Avenue Syracuse, NY 13210-2716 has a requirement for a United States Nuclear Regulatory Commission (US NRC) and Food and Drug Administration (FDA) Licensed Contractor to provide radiopharmaceuticals for the Nuclear Medicine Department for patient care. The Syracuse VA Medical Center (VAMC) intends to award a base year plus two option years, firm fixed price, indefinite delivery, indefinite quantity requirements contract to a licensed Radiopharmacy authorized to manufacture and distribute Radiopharmaceutical Supplies and Services in New York State with a period of performance of December 1, 2020 through November 30, 2023. The Contractor agrees in accordance with the terms and conditions stated herein, to furnish Radiopharmaceuticals in accordance with Federal, State and Local Regulations. Further, the Contractor will use non-HEU derived isotopes whenever possible to support the Department of Veterans Affairs procurement initiative. The Contractor shall be able to provide all the items listed in the Schedule of Radiopharmaceuticals with deliveries when required. Multiple awards will not be made, and subcontracting is not authorized.

CLIN
Description Of Supplies
Guaranteed Minimum
Maximum Amount

Ordering Period #1: December 1, 2020 through November 30, 20230

0001
Radiopharmaceuticals in accordance with this Statement of Work.

Purchase Order: Provided After IDIQ Award

$450,000.00
$1,000,000.00

BACKGROUND

The Syracuse VA Medical Center (VAMC) is responsible for providing high quality and timely commodities and services for our Veterans. One area to serve our Veterans is to ensure that the best possible medical supplies are both timely and in accordance with proper regulations with Contractors that are licensed and monitored according to Federal, State and Local Regulations. Under the Atomic Energy Act, the United States Nuclear Regulatory Commission (US NRC) is responsible for regulating uses of radioactive material, including radiopharmaceuticals. The US NRC requires all nuclear medicine facilities to be licensed. The license assures that the facility has a radiation protection program to protect both the patients and the staff. In addition, the staff must meet certain standards of training and experience before they can administer radioactive material to patients. Each state has one or more radiation programs that ensure safe use of radioactive materials. The US NRC has transferred regulatory authority over the use of this material to 35 NRC Agreement States. In these states, the regulatory authority inspects the facility to ensure the staff is trained properly and the equipment is operating safely. FDA s Center for Drug Evaluation and Research regulates the radiopharmaceuticals, ensuring effectiveness and patient safety. The mission of The National Institute of Standards and Technology (NIST) is to develop and promote measurement, standards, and technology to enhance productivity, facilitate trade, and improve the quality of life.

All deliveries will be labeled as RADIOACTIVE MATERIAL in compliance with all applicable regulations. All shipments must have a Packing Slip enclosed, giving information about the product and its identification, plus (for billing purposes) the Syracuse VAMC Purchase Order Number issued for the current fiscal year, and the Contractor’s invoice number. Providing incorrect Purchase Order numbers on invoices will cause a substantial delay in payments to the Contractor.

See the Statement of Work for the Schedule of Required Radiopharmaceuticals.

52.212-2 EVALUATION COMMERCIAL ITEMS (October 2014) The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be most advantageous to the Government, price, and other factors considered. The following factors shall be used to evaluate offers: Technical Approach and Capability, Past Performance, and Price.

Factor I - Technical Approach and Capability

Subfactor 1: The Offeror must include a copy of their Nuclear Pharmacy License.

Subfactor 2: The Offeror must demonstrate their ability to deliver products Monday through Friday by 7:00 AM Eastern Standard Time. The Contractor must provide a MapQuest illustration showing their ability to meet these delivery requirements time frames.

Subfactor 3: The Offeror must provide an emergency procedure plan for deliveries during periods of inclement weather.

Factor II - Past Performance

The Offeror shall provide a minimum of three (3) references of current contracts within the past three years of similar size, scope, and or complexity. References may include Federal, State, and Local Government as well as private customers and shall include the following information:

· Name and address of the Contracting Activity to include the Medical Center or Company.

· Names, email addresses, and telephone numbers of two points of contact (Contracting Officer and Customer) that would have firsthand knowledge on the performance of the contract.

· Contract type, scope of work, and contract total dollar value.

· Contract number to include the beginning date and ending date of the contract period of performance.

· The past performance evaluation factor will assess the relevance and breadth of the offeror s experience and the quality of the offeror s past performance.

The Government is seeking to determine whether the offeror has experience that will enhance its technical capability to perform and whether the offeror consistently delivers quality services in a timely and cost-effective manner. In evaluating past performance, the Government will only take into consideration the relevant experience from the offeror s customers. Information obtained from the offerors through the PPIRS database and any other sources deemed appropriate will be used by the Government in conducting past performance evaluations. The Government will analyze the historical facts of the offerors past performance made by its customers, make qualitative judgements about the facts and observations. Offerors may provide information on problems encountered on identified contracts and the offeror s corrective action. The Government shall determine the relevance of similar past performance information. In accordance with FAR 15.305(a)(2)(iv) offerors with no relevant performance history shall not be evaluated favorably or unfavorably on the past performance factor.

Factor III – Price

In accordance with FAR 17.206, price will be evaluated for the entire contract period, including the base year and both option years. Price evaluation will be undertaken in accordance with FAR 12.209.

All evaluation factors except price shall be evaluated as either acceptable or unacceptable. Your proposal must meet all the requirements identified in the SOW. If your proposal does not meet all the SOW requirements it will be evaluated as unacceptable and will receive no further consideration for award. If your proposal does not provide pricing for all the Schedule of Radiopharmaceuticals, it will be evaluated as unacceptable and will receive no further consideration for award. When providing pricing information Offerors need to complete all four columns which are: Price For Each mCi or Bulk, Total Price, Number of Minutes Needed to Prepare Product at Radiopharmacy, and NDC Of Offered Product. Price is the most important evaluation factor, followed by technical approach and capability, and then past performance.

At a minimum, proposals must include the following:

Offerors must return provision 52.212-3 with their quote. Offerors may either (1) complete all relevant portions of the provision or (2) complete paragraph of the provision and indicate that it has completed official representations and certifications online at sam.gov.

· Company name, phone number, and fax number.

· Company point of contact name, email address, and phone number.

· Company Mailing address and Remit to address, if different than mailing address.

· Acknowledgment of Solicitation Amendment(s) if applicable.

· Offeror's Federal Tax ID Number.

· Offeror's DUNS number.

· Offeror s Business Size.

· Offeror must provide copies of all required licenses and certifications as identified in the SOW.

· A detailed statement regarding the offerors emergency plan for providing deliveries during periods of inclement weather.

· MapQuest illustration demonstrating that the offeror can make all deliveries within two hours.

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and the Syracuse VA Nuclear Medicine Department anticipates entering into a contract for radiopharmaceuticals. The solicitation number is 36C242-21-Q-0158 and the solicitation is issued as a request for quotation (RFQ). This combined synopsis solicitation will result in the award of a Requirements Contract along with the corresponding Delivery order and Purchase Order for each fiscal year of the contract. The provisions and clauses incorporated into this solicitation document are those in effect at the time of publication. Provisions and clauses incorporated by reference have the same force and effect as if they were given in full text. The full text of the Federal Acquisition Regulations (FAR) and Veterans Affairs Acquisition Regulations supplement (VAAR) can be accessed on the Internet at https://www.acquisition.gov/far/ http://www.va.gov/oamm/oa/ars/policyreg/vaar/ , respectively.

The North American Industry Classification System (NAICS) code is 325412 with a size standard of 1250 employees applies to this solicitation. This requirement consists of supplying radiopharmaceuticals. The period of performance for the awarded contract will be from December 1, 2020 through November 30, 2023.

Delivery of radiopharmaceuticals will be to the Syracuse VA Medical Center ~ Nuclear Medicine Department, 800 Irving Avenue, Syracuse, NY 13210.

The following solicitation provisions and contract clauses apply:

FAR 52.202-1, Definitions (November 2013) FAR 52.203-3, Gratuities (April 1984) FAR 52.203-6, Alt I- Restrictions on Subcontractor Sales to the Government (September 2006) FAR 52.203-11, Certification & Disclosure Regarding Payments to Influence Certain Federal Transactions (September 2007) FAR 52.203-12, Limitation on Payments to Influence Certain Federal Transactions (October 2010) FAR 52.203-17, Contractor Employee Whistleblower Rights and Requirement To Inform Employees of Whistleblower Rights (April 2014) FAR 52.204-4, Printed or Copied Double-Sided on Recycled Paper (May 2011) FAR 52.204-7, System for Award Management (October 2016) FAR 52.209-2, Prohibition on Contracting with inverted Domestic Corporations Representation (November 2015) FAR 52.209-5, Certification Regarding Responsibility Matters (October 2015) FAR 52.212-1, Instructions to Offerors - Commercial Items (January 2017) FAR 52.212-3, Offeror Representations and Certification, Commercial Items (January 2017). Offerors must include a completed copy of the provision with its offer or fill out online representations and certifications at 52.212-1 Instructions to Offerors Commercial Items.

FAR 52-212-4, Contract Terms and Conditions - Commercial Items (January 2017) FAR 52.212-5, Contracts Terms and Conditions Required to Implement Statutes or Executive Orders - Commercial Items (January 2017). For the purposes of this clauses, items (b), 1, 4, 6, 7 14, 26, 27, 28, 29, 30, 31, 32, 33, and 48 are considered checked and apply.

FAR 52.216-21, Requirements (October 1995) FAR 512.217-4, Evaluation of Options Exercised at Time of Contract Award (June 1988) FAR 52.217-5, Evaluation of Options (July 1990) FAR 52.217-6 Option for Increased Quantity (March1989) FAR 52.217-8 Option to Extend Services (November 1999) FAR 52.217-9, Option to Extend the Term of the Contract (March 2000) FAR 52.222-3, Convict Labor (June 2003) FAR 52.222-19, Child Labor Cooperation with Authorities and Remedies (October 2016) FAR 52.222-36, Equal Opportunity for Workers with Disabilities (July 2014) FAR 52.222-50, Combating Trafficking in Persons (March 2015) FAR 52.223-3, Hazardous Material Identification and Material Safety Data (January 1997) FAR 52.223-18, Contractor Policy to Ban Text Messaging While Driving (August 2011) FAR 52.225-1, Buy American Supplies (May 2014) FAR 52.232-18, Availability of Funds (April 1984) FAR 52.232-19, Availability of Funds for the Next Fiscal Year (April 1984) FAR 52.232-33, Payment by Electronic Funds Transfer (July 2013) FAR 52.232-38, Submission of Electronic Funds Transfer Information with Offer (July 2013) FAR 52.233-3, Protest After Award (August 1996) FAR 52.233-4, Applicable Law for Breach of Contract Claim (October 2004) FAR 52.246-2, Inspection of Supplies Fixed Price (August 1996) FAR 52.247-34 F.o.b. Destination (November 1991) FAR 52.252-1, Solicitation Provisions Incorporated by Reference (February 1998). For the purpose of this provision, the fill-in s are http://farsite.hill.af.mil/ and http://farsite.hill.af.mil/vffara.htm respectively.

FAR 52.252-2, Clauses Incorporated by Reference (February 1998). For the purpose of this provision, the fill-in s are http://farsite.hill.af.mil/ and http://farsite.hill.af.mil/vffara.htm respectively.

VAAR 852.203-70, Commercial Advertising (January 2008) VAAR 852.215-70, Service Disabled Veteran Owned And Veteran Owned Small Business Evaluation Factors (December 2009) VAAR 852.216-70, Estimated Quantities (April 1984) VAAR 852.232-72, Electronic Submission of Payment Requests (November 2012) VAAR 852.246-71, Inspection (January 2008) VAAR 852.270-1, Representatives of Contracting Officers (January 2008) VAAR 852.271-75, Extension Of Contract Period (April 1984) VAAR 852.273-74, Award Without Exchanges (January 2003)

Proposals are due no later than Thursday, November 12, 2020 @ 4:00 PM Eastern Standard Time, include the solicitation # (36C242-21-Q-0158) on your subject line. Use electronic mail to submit proposals to Denise.Edmonds@va.gov and ensure that your proposal is signed and dated. Telephone inquiries will not be accepted. Please submit any questions regarding this solicitation via email no later than Thursday, November 12, 2020 ~ 12:00 PM Eastern Standard Time.

File details come from the government source that posted it. Updated .